Most prestigious and popular scientific research of Julio Licinio
Posted by JulioLicinio on February 13th, 2019
Julio Licinio is the most popular psychiatry from Australia. His field commitment in the field of prescription is quite commendable. He discovered how antidepressants can expand the weight and prompt stoutness. He is doing amazing work in the prescription field of 30 years. In this period he is a renowned delegate executive of interpretation technique and process for the head, mind, and brain theme at the South Australian Health and Research Institute in Adelaide, Australia. Dr. Julio Licinio has finished his therapeutic investigation from the Brazilian University of Bahia School of Medicine and finished his residency at the University of Sao Paulo Medical Center, Brazil. He was the former fellow and assistant professor of Psychiatry at Yale University.
Julio Licinio's International Research About Leptin
Julio Licinio is known for his depth in research of leptin and it's a role in conveying the feeling of satiety. IN this he identified three people from turkey who suffered from the leptin disorder and all of them are severely overweight. He administered daily about the leptin injections to each of them and found that all the patients lost half of their weight in 10 months. He discovered that despite the production of the dispersed mass of fat cells, leptin is secreted in a highly organized manner with distinct pulse rate that appears to regulate the minute rhythms of several endocrine axes. These axes include a hypothalamic pituitary gonadal axis, hypothalamic pituitary adrenal axis, and hypothalamic thyroid axis. Julio Licinio had some colleagues who suggested that leptin may have anti-depressant effects and then that idea is extended in a further way. He also contributes to pioneer concepts that leptin has pro-cognitive effects in humans.
With the group, Julio Licinio conducted an extensive body test to evaluate more about the pharmacogenomics of depression which is started in the year 2000. This evaluation was done in National Institute of General Medical Sciences NIH Pharmacogenomics Research Network (PRGN). He also did whole research in the major depressive disorder in Los-Angeles. His pharmacogenetics research has resulted in the creation of several publication documents on predictors of anti-depressant treatment response in this population. He has received certificates and commendations both from the California State Legislature and the United States Congress.
